Industry executives: Profits drive rising prices for MS drugs

Pharmaceutical industry executives, speaking confidentially, paint a frank picture of the rationale behind the price of medication available to people with multiple sclerosis.

source https://www.sciencedaily.com/releases/2019/11/191125173501.htm

Comments